{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:38:06Z","timestamp":1792147086909,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jaad.2012.05.035","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T04:46:33Z","timestamp":1344487593000},"page":"1327.e1-1327.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Fas apoptotic pathway in cutaneous T-cell lymphomas: Frequent expression of phenotypes associated with resistance to apoptosis"],"prefix":"10.1016","volume":"67","author":[{"given":"Nathalie","family":"Stutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.05.035_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0560.1995.tb00733.x","article-title":"Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates","volume":"22","author":"Dummer","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2012.05.035_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-2133.2001.04523.x","article-title":"Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis","volume":"145","author":"Nevala","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.05.035_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1396-0296.2003.01648.x","article-title":"Systemic chemotherapy for the treatment of mycosis fungoides and Sezary syndrome","volume":"16","author":"Kuzel","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2012.05.035_bib4","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2012.05.035_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri2115","article-title":"Life and death in peripheral T cells","volume":"7","author":"Krammer","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2012.05.035_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.05.035_bib7","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/sj.jid.5700868","article-title":"Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells","volume":"127","author":"Braun","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.05.035_bib8","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2007-08-109074","article-title":"Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression","volume":"111","author":"Contassot","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2012.05.035_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12312548","article-title":"Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin","volume":"105","author":"Wood","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.05.035_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2133.2000.03656.x","article-title":"Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL","volume":"143","author":"Zoi-Toli","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.05.035_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/modpathol.3880076","article-title":"Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L","volume":"13","author":"Sigel","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2012.05.035_bib12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0046-8177(98)90249-0","article-title":"Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily","volume":"29","author":"Paulli","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2012.05.035_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2559.1995.tb00215.x","article-title":"Frequent expression of FAS\/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas","volume":"27","author":"Xerri","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2012.05.035_bib14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2559.2007.02882.x","article-title":"Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation","volume":"51","author":"van Houdt","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2012.05.035_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archdermatol.2010.376","article-title":"Reduction of Fas\/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma","volume":"147","author":"Wu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.05.035_bib16","first-page":"836","article-title":"Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides\/Sezary syndrome","volume":"22","author":"Aviles","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.05.035_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00292-010-1372-4","article-title":"cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells [in German]","volume":"31","author":"Hirsch","year":"2010","journal-title":"Pathologe"},{"key":"10.1016\/j.jaad.2012.05.035_bib18","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood-2005-06-2601","article-title":"c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma","volume":"107","author":"Oyarzo","year":"2006","journal-title":"Blood"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212006378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212006378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:26:13Z","timestamp":1759271173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212006378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0190962212006378"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.05.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Fas apoptotic pathway in cutaneous T-cell lymphomas: Frequent expression of phenotypes associated with resistance to apoptosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2012.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}